Hindman Andrew A. 4
4 · Theravance Biopharma, Inc. · Filed May 24, 2021
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-05-20$17.80/sh−942$16,768→ 184,844 total
Footnotes (1)
- [F1]Includes 1,082 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.